Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Zhejiang Pushkang Biotechnology Co. Ltd. currently faces 1 pending office action in the Chemistry & Materials technology area. This prosecution is being handled by 1 distinct examiner within 1 distinct art unit. This concentration indicates a specific technical focus for the company's active patent matters. Operating within 1 distinct art unit allows the company to develop a deep understanding of the specific examination trends prevalent in that technical area.
MELLON, DAVID C is the busiest examiner for the portfolio, managing 1 pending office action. This busiest examiner pending count of 1 accounts for all current office actions identified in the data. With 1 distinct art unit involved, the company's legal strategy is currently focused on this administrative division. The company's success in this matter will depend on effectively addressing the specific feedback provided by 1 distinct examiner during the examination phase.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MELLON, DAVID C | 1 | 66.4% | +17.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17924114 | CENTRIFUGAL DETECTION CHANNEL, DETECTION DEVICE AND DETECTION METHOD | MELLON, DAVID C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17924114 | CENTRIFUGAL DETECTION CHANNEL, DETECTION DEVICE AND DETECTION METHOD | MELLON, DAVID C | — |
| Art Unit | Apps |
|---|---|
| 1700 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17924114 | CENTRIFUGAL DETECTION CHANNEL, DETECTION DEVICE AND DETECTION METHOD | MELLON, DAVID C | 1700 | §102§112 | Final Rejection | — | Pending | Nov 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialZhejiang Pushkang Biotechnology Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
David C Mellon has the most, with 1 of Zhejiang Pushkang Biotechnology Co. Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
